BioLineRx BLRX
NASDAQ BLRX
$2.21 +0.23 (+12.40%)
As of: Oct 20, 2026 · 2:30 PM EDT

BioLineRx (BLRX) Other Operating Expenses (2010 - 2011)

Updated

Analysis

BioLineRx (BLRX) Other Operating Expenses (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 BioLineRx 9.10 Mn -67.42 Mn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 583,846.17
Jun 30, 2010 443,892.95
API Access

BioLineRx Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEY